ONC vs ROIV
BeOne Medicines AG and Roivant Sciences Ltd., both Healthcare
BeOne Medicines AG is the larger company at $29B against $24B. Over the past year ROIV returned +136% against +5.9% for ONC.
| Figure | ONC | ROIV |
|---|---|---|
| Last close | $354 | $35.42 |
| Market cap | $29B | $24B |
| 1-year return | +5.9% | +136% |
| 5-year return | -4.0% | +255% |
| RyuScoresector-relative, 1–10 | n/a | 42/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
BeOne Medicines AG
Roivant Sciences Ltd.
Revenue of $1M in Q1 2026, net income null.
Open these two in the interactive comparison to add more names, change the period or see the correlation.